What non-benzodiazepine (non-benzo) medications can be used as needed (prn) for anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Non-Benzodiazepine PRN Medications for Anxiety

Buspirone is the primary non-benzodiazepine medication that can be used for anxiety, but it is NOT suitable for PRN (as-needed) use because it requires 1-2 weeks of continuous daily dosing to achieve anxiolytic effects. 1, 2, 3, 4

Critical Limitation: No True PRN Non-Benzodiazepine Options

There are no FDA-approved non-benzodiazepine medications that work effectively on an as-needed basis for acute anxiety. The fundamental problem is that all effective non-benzodiazepine anxiolytics require regular, scheduled dosing to build therapeutic effect:

Buspirone (BuSpar) - Requires Daily Dosing

  • Buspirone is an azapirone anxiolytic that is chemically and pharmacologically unrelated to benzodiazepines 2
  • Requires 1-2 weeks of continuous daily administration before anxiolytic effects begin 3, 4
  • Typical dosing: 15-30 mg/day in divided doses (starting at 5 mg twice daily, titrating upward) 1, 2
  • Major advantage: lacks sedation, muscle relaxation, anticonvulsant effects, and has minimal abuse/dependence potential 3, 5
  • Does not impair psychomotor or cognitive function and has no additive effect with alcohol 3
  • Most appropriate for patients with generalized anxiety disorder requiring chronic treatment, elderly patients, and those with mixed anxiety/depression 4
  • Not effective for panic disorder 4
  • Contraindicated with MAOIs due to risk of elevated blood pressure and serotonin syndrome 2

SSRIs/SNRIs - Require Daily Dosing

  • SSRIs (like fluoxetine) and SNRIs (like duloxetine, venlafaxine) are effective for anxiety but require weeks of daily dosing to achieve therapeutic effect 1
  • These are first-line treatments for chronic anxiety disorders but have zero utility for PRN use 1
  • Duloxetine is FDA-approved for generalized anxiety disorder in children ≥7 years 1

Alternative Approaches When PRN Relief Is Needed

Antihistamines (Off-Label)

  • Hydroxyzine is sometimes used off-label for acute anxiety, though this is not mentioned in the provided guidelines
  • Works within 30-60 minutes but causes sedation
  • No dependence risk but anticholinergic side effects limit use, especially in elderly

Gabapentinoids - Limited Single-Dose Use

  • Gabapentin and pregabalin can provide anxiolysis with a single preoperative dose 1
  • However, benefits are offset by sedation, dizziness, and visual disturbances 1
  • Should be limited to single lowest dose to avoid sedative side effects 1
  • Dose adjustment required for elderly and renal dysfunction 1
  • Not recommended for routine PRN anxiety management outside perioperative settings

Why Benzodiazepines Remain the Only True PRN Option

Despite significant risks, benzodiazepines remain the only medication class with rapid onset (15-30 minutes) suitable for true PRN anxiety management. 1, 6 However:

  • Current guidelines do not recommend benzodiazepines for anxiety treatment exceeding one year 6
  • Long-term use causes physical dependence and withdrawal symptoms 1, 6
  • Gradual tapering (25% dose reduction every 1-2 weeks) is required when discontinuing 6
  • Short-acting agents (lorazepam, oxazepam) are least problematic for infrequent use 1
  • Paradoxical agitation occurs in ~10% of patients 1

Clinical Bottom Line

If a patient requires PRN medication for acute anxiety episodes, you must either:

  1. Accept the risks of infrequent, low-dose short-acting benzodiazepines 1, 6
  2. Transition to scheduled daily buspirone (15-30 mg/day) and use non-pharmacologic interventions for breakthrough anxiety 1, 2, 4
  3. Implement psychotherapy and behavioral interventions as the primary PRN strategy 1

The notion of a "safe PRN non-benzodiazepine anxiolytic" is largely a myth in current clinical practice - no such medication exists with both rapid onset and proven efficacy for as-needed use.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Buspirone in clinical practice.

The Journal of clinical psychiatry, 1990

Research

Nonbenzodiazepine anxiolytics: clinical usefulness.

The Journal of clinical psychiatry, 1983

Guideline

Benzodiazepines in Anxiety Disorder Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.